关于Covid-19与叠加性肺组织等离子体病的见解:可能的关联
Yahya A Almutawif1, Hayder M Al-Kuraishy2, Ali I Al-Gareeb2
1Department of Medical Laboratories Technology, College of Applied Medical Sciences, Taibah University, Madinah, Saudi Arabia.
本综述探讨了COVID-19肺炎和肺部组织等离子体病之间的联系. 在COVID-19中,免疫调节失调和炎症可能会增加细胞体质症的风险和严重程度.
科学领域:
- 传染性疾病 传染性疾病
- 免疫学 免疫学 免疫学
- 肺部病理学 肺部病理学
背景情况:
- 严重急性呼吸系统综合征冠状病毒2 (SARS-CoV-2) 是导致COVID-19的原因.
- COVID-19涉及免疫调节失调,肺损伤和炎症.
- 肺组织等离子体病是一种肺部的真菌感染.
研究的目的:
- 为了调查COVID-19肺炎和肺部组织等离子体病变之间的潜在联系.
- 检查免疫反应在这种相互作用中的作用.
- 了解这些情况如何影响对方的严重程度和进展.
主要方法:
- 这项研究是对现有文献的批判性审查.
- 它分析了SARS-CoV-2和Histoplasma capsulatum之间的免疫相互作用的研究.
- 该评论综合了关于免疫失调,炎症和淋巴缺血的发现.
主要成果:
- 通过免疫失调和炎症,COVID-19可能会增加肺组织等离子体病的风险和严重程度.
- 在严重的COVID-19中使用皮质类固醇可能会重新激活潜伏的组织等离子体.
- 在组织等离子体中激活的炎症通路可能会加剧COVID-19的严重程度,反之亦然.
- 在COVID-19中淋巴缺血可能会导致细胞质的进展.
结论:
- 在复杂的免疫相互作用中介的COVID-19肺炎和肺组织等离子体病之间存在显著的潜在联系.
- 了解这种关系对于管理与SARS-CoV-2和Histoplasma共感染的患者至关重要.
- 需要进一步的研究来阐明精确的机制和临床影响.
更多相关视频
07:21Processing of Bronchoalveolar Lavage Fluid and Matched Blood for Alveolar Macrophage and CD4+ T-cell Immunophenotyping and HIV Reservoir Assessment
Published on: June 23, 2019
03:53Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses
Published on: November 10, 2023
相关概念视频
Pneumonia II: Pathophysiology
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
